Previous studies have demonstrated that rFIPs (rFIP-nha from N. haematococca and rFIP-ppl from P. placenta) that were expressed in E. coli significantly inhibited the growth of several types of cancer cells and induced apoptosis, and the anti-tumour effects were cell-specific [18, 19]. The gene discussed is PPL; the disease is cancer.